Immunotherapy with the bispecific antibody MDX-H210 (anti-HER2 × anti-CD64) combined with GM-CSF in HER2 positive hormone resistant prostatic cancer

✍ Scribed by James, N.D.; Atherton, P.J.; Howie, A.J.; Tchekmedyian, S.; Curnow, R.T.

• Book ID: 123234754
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 318 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(99)81804-8